Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Patrick James Lynch: Speaking About the Risks and Benefits of Rebalancing Agents to Treat Hemophilia
Apr 29, 2026, 15:01

Patrick James Lynch: Speaking About the Risks and Benefits of Rebalancing Agents to Treat Hemophilia

Patrick James Lynch, the CEO of Believe Limited, shared Global Hemophilia Report‘s post on LinkedIn:

“Thank you, Cedric Hermans, for speaking about the risks and benefits of rebalancing agents to treat hemophilia on the latest episode of the Global Hemophilia Report podcast.

Listen to Dr. Hermans along with Shannon Carpenter, Donna DiMichele, and CJ Hansen discuss the role of rebalancing agents.”

Global Hemophilia Report shared a post on LinkedIn:

“Too much clotting is dangerous.

Too little causes bleeding.

On the latest Global Hemophilia Report, Dr. Cedric Hermans dives into how rebalancing agents strike the delicate middle ground for certain patients -because achieving zero bleeds takes balance.

Guests:

  • Dr. Cedric Hermans, MD, – Hemophilia Centre, Saint-Luc University Hospital, Brussels
  • Dr. Shannon Carpenter, MD – Pediatric Hematology, Kansas City Hemophilia Center:
  • CJ Hansen BSN, RN – Nurse Coordinator and Program Manager, OSU Comprehensive Cancer Center, Patient Advocate

Hosted by: Patrick James Lynch

Listen, Rate, Review, and Subscribe to Global Hemophilia Report where you get your podcasts

Supported through advertising by Sanofi.”

Proceed to the video attached to the post.

Stay updated with Hemostasis Today.